{"name": "ElsaLys Biotech",
 "permalink": "elsalys-biotech",
 "crunchbase_url": "http://www.crunchbase.com/company/elsalys-biotech",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Fri May 17 12:56:25 UTC 2013",
 "updated_at": "Mon May 20 06:21:23 UTC 2013",
 "overview": "\u003Cp\u003EElsaLys Biotech, a Lyon \u0026amp; Illkirch Graffenstaden-France-based developer of therapeutic monoclonal antibodies, raised \u20ac2.1m in its first round of financing.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[66,
       70],
      "assets/images/resized/0026/4280/264280v1-max-150x150.jpg"],
     [[66,
       70],
      "assets/images/resized/0026/4280/264280v1-max-250x250.jpg"],
     [[66,
       70],
      "assets/images/resized/0026/4280/264280v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Dr",
      "last_name": "Jean-Yves Bonnefoy",
      "permalink": "dr-jean-yves-bonnefoy",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "Dr",
      "last_name": "Christine Guillen",
      "permalink": "dr-christine-guillen",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac2.1M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2013/05/elsalys-biotech-raises-e2-1m-financing.html",
    "source_description": "ElsaLys Biotech Raises \u20ac2.1M in First Financing",
    "raised_amount": 2100000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 17,
    "investments":
     [{"company":
        {"name": "Transgene",
         "permalink": "transgene",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0026/3557/263557v1-max-150x150.jpg"],
             [[249,
               84],
              "assets/images/resized/0026/3557/263557v1-max-250x250.jpg"],
             [[249,
               84],
              "assets/images/resized/0026/3557/263557v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sofimac Partners",
         "permalink": "sofimac-partners",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0005/1483/51483v1-max-150x150.jpg"],
             [[240,
               116],
              "assets/images/resized/0005/1483/51483v1-max-250x250.jpg"],
             [[240,
               116],
              "assets/images/resized/0005/1483/51483v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}